ArticlePloS one2015

Classification of Epidermal Growth Factor Receptor Gene Mutation Status Using Serum Proteomic Profiling Predicts Tumor Response in Patients with Stage IIIB or IV Non-Small-Cell Lung Cancer.

Lin Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.